Europe Topical Drug Delivery Market
In this region, The Europe topical drug delivery market is expected to reach USD 60.3 billion by 2024, from USD 31.3 billion in 2016 growing at a CAGR of 8.5% in the forecast period 2017 to 2024.
Based on geography, the Europe topical drug delivery market is segmented into 11 geographical regions, such as,
Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the Europe topical drug delivery market are
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.
Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.
The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.
On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others. On the basis of distribution channel the market is segmented into direct tenders, and retails.
Based on geography, the Europe topical drug delivery market is segmented into 11 geographical regions, such as,
- Germany,
- France,
- United Kingdom,
- Italy,
- Spain,
- Russia,
- Turkey,
- Belgium,
- Netherlands,
- Switzerland and
- Rest of Europe.
Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the Europe topical drug delivery market are
- MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company),
- Crescita Therapeutics,
- West Pharmaceutical Services,
- Biofarmitalia s.r.l,
- Pharmatek Laboratories, Inc.,
- Stiefel Laboratories, Inc.,
- Tapemark, Acrux Limited,
- Nitto Denko Corporation,
- Skinvisible Pharmaceuticals, Inc.,
- Mylan Pharmaceuticals Inc.,
- Pocono Coated Products LLC,
- TheraSolve NV.,
- Samyang Biopharmaceuticals Corporation,
- Lohmann Therapie-Systeme AG,
- Prosollus Pharmaceuticals,
- Easton Pharmaceuticals Inc.,
- Novosis AG,
- Endo Pharmaceuticals Inc.,
- Transdermal Technologies, Inc.,
- Sheffield Pharmaceuticals, Inc.,
- Solvay
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.
Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.
The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.
On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others. On the basis of distribution channel the market is segmented into direct tenders, and retails.
1. INTRODUCTION
1.1. OVERVIEW OF EUROPE TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
3.1.2. RISING AGING POPULATION
3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
3.1.4. APPROVAL OF NEW DRUGS
3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE
3.3. OPPORTUNITY
3.3.1. ENERGING MARKET
3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. PRODUCT RECALL
3.4.2. PENETRATION INTO THE SMALLER MARKETS
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. EUROPE TOPICAL DRUG DELIVERY MARKET, BY TYPE
6.1. OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
7. EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.1. OVERVIEW
7.2. EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. EUROPE ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
8. EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. EUROPE TOPICAL DRUG DELIVERY MARKET, BY END USER
9.1. OVERVIEW
10. EUROPE TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. EUROPE TOPICAL DRUG DELIVERY MARKET
10.2.1. GERMANY TOPICAL DRUG DELIVERY MARKET
10.2.2. FRANCE TOPICAL DRUG DELIVERY MARKET
10.2.3. ITALY TOPICAL DRUG DELIVERY MARKET
10.2.4. U.K. TOPICAL DRUG DELIVERY MARKET
10.2.5. SWITZERLAND TOPICAL DRUG DELIVERY MARKET
10.2.6. SPAIN TOPICAL DRUG DELIVERY MARKET
10.2.7. NETHERLAND TOPICAL DRUG DELIVERY MARKET
10.2.8. RUSSIA TOPICAL DRUG DELIVERY MARKET
10.2.9. TURKEY TOPICAL DRUG DELIVERY MARKET
10.2.10. BELGIUM TOPICAL DRUG DELIVERY MARKET
10.2.11. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET
11. EUROPE TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: EUROPE
12. COMPANY PROFILES
12.1. GALDERMA PHARMA S.A.
12.1.1. COMPANY OVERVIEW
12.1.2. FINANCIAL OVERVIEW
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. HISAMITSU PHARMACEUTICAL CO., INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. PFIZER INC.
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. ABBVIE INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. BAYER AG
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. 3M
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. ANTARES PHARMA, INC.
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. ALLERGAN PLC.
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. KAKEN PHARMACEUTICALS CO., LTD
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
13. RELATED REPORTS
TABLE LIST
TABLE 1 EUROPE TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
TABLE 2 EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 3 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 4 EUROPE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 5 EUROPE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 6 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 7 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 8 EUROPE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 9 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 10 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 11 EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 12 GERMANY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 13 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 14 GERMANY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 15 GERMANY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 16 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 17 GERMANY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION
TABLE 18 GERMANY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 19 GERMANY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 20 FRANCE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 21 FRANCE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 22 FRANCE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 23 FRANCE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 24 FRANCE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 25 FRANCE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 26 FRANCE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 27 FRANCE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 28 ITALY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 29 ITALY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 30 ITALY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 31 ITALY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 32 ITALY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 33 ITALY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 34 ITALY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 35 ITALY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 36 UK TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 37 UK TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 38 UK TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 39 UK SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 40 UK LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 41 UK SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 42 UK TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 43 UK TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 44 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 45 SWITZERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 46 SWITZERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 47 SWITZERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 48 SWITZERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 49 SWITZERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 50 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 51 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 52 SPAIN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 53 SPAIN TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 54 SPAIN TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 55 SPAIN SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 56 SPAIN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 57 SPAIN SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 58 SPAIN TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 59 SPAIN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 60 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 61 NETHERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 62 NETHERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 63 NETHERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 64 NETHERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 65 NETHERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 66 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 67 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 68 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 69 RUSSIA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 70 RUSSIA TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 71 RUSSIA SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 72 RUSSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 73 RUSSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 74 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 75 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 76 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 77 TURKEY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 78 TURKEY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 79 TURKEY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 80 TURKEY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 81 TURKEY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 82 TURKEY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 83 TURKEY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 84 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 85 BELGIUM TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 86 BELGIUM TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 87 BELGIUM SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 88 BELGIUM LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 89 BELGIUM SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 90 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 91 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION
TABLE 92 REST OF EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
1.1. OVERVIEW OF EUROPE TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
3.1.2. RISING AGING POPULATION
3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
3.1.4. APPROVAL OF NEW DRUGS
3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS
3.2. RESTRAINTS
3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE
3.3. OPPORTUNITY
3.3.1. ENERGING MARKET
3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. PRODUCT RECALL
3.4.2. PENETRATION INTO THE SMALLER MARKETS
4. PREMIUM INSIGHTS
5. EXECUTIVE SUMMARY
6. EUROPE TOPICAL DRUG DELIVERY MARKET, BY TYPE
6.1. OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
7. EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.1. OVERVIEW
7.2. EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. EUROPE ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION
8. EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
9. EUROPE TOPICAL DRUG DELIVERY MARKET, BY END USER
9.1. OVERVIEW
10. EUROPE TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. EUROPE TOPICAL DRUG DELIVERY MARKET
10.2.1. GERMANY TOPICAL DRUG DELIVERY MARKET
10.2.2. FRANCE TOPICAL DRUG DELIVERY MARKET
10.2.3. ITALY TOPICAL DRUG DELIVERY MARKET
10.2.4. U.K. TOPICAL DRUG DELIVERY MARKET
10.2.5. SWITZERLAND TOPICAL DRUG DELIVERY MARKET
10.2.6. SPAIN TOPICAL DRUG DELIVERY MARKET
10.2.7. NETHERLAND TOPICAL DRUG DELIVERY MARKET
10.2.8. RUSSIA TOPICAL DRUG DELIVERY MARKET
10.2.9. TURKEY TOPICAL DRUG DELIVERY MARKET
10.2.10. BELGIUM TOPICAL DRUG DELIVERY MARKET
10.2.11. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET
11. EUROPE TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: EUROPE
12. COMPANY PROFILES
12.1. GALDERMA PHARMA S.A.
12.1.1. COMPANY OVERVIEW
12.1.2. FINANCIAL OVERVIEW
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. HISAMITSU PHARMACEUTICAL CO., INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. PFIZER INC.
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. ABBVIE INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. BAYER AG
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. 3M
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. ANTARES PHARMA, INC.
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. ALLERGAN PLC.
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. KAKEN PHARMACEUTICALS CO., LTD
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
13. RELATED REPORTS
TABLE LIST
TABLE 1 EUROPE TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
TABLE 2 EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 3 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 4 EUROPE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 5 EUROPE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 6 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 7 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 8 EUROPE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 9 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 10 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 11 EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 12 GERMANY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 13 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 14 GERMANY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 15 GERMANY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 16 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 17 GERMANY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION
TABLE 18 GERMANY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 19 GERMANY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 20 FRANCE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 21 FRANCE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 22 FRANCE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 23 FRANCE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 24 FRANCE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 25 FRANCE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 26 FRANCE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 27 FRANCE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 28 ITALY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 29 ITALY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 30 ITALY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 31 ITALY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 32 ITALY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 33 ITALY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 34 ITALY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 35 ITALY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 36 UK TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 37 UK TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 38 UK TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 39 UK SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 40 UK LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 41 UK SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 42 UK TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 43 UK TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 44 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 45 SWITZERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 46 SWITZERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 47 SWITZERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 48 SWITZERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 49 SWITZERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 50 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 51 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 52 SPAIN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 53 SPAIN TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 54 SPAIN TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 55 SPAIN SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 56 SPAIN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 57 SPAIN SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 58 SPAIN TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 59 SPAIN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 60 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 61 NETHERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 62 NETHERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 63 NETHERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 64 NETHERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 65 NETHERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 66 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 67 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 68 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 69 RUSSIA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 70 RUSSIA TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 71 RUSSIA SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 72 RUSSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 73 RUSSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 74 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 75 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 76 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 77 TURKEY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 78 TURKEY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 79 TURKEY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 80 TURKEY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 81 TURKEY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 82 TURKEY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 83 TURKEY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION)
TABLE 84 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 85 BELGIUM TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 86 BELGIUM TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 87 BELGIUM SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 88 BELGIUM LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 89 BELGIUM SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 90 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 91 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION
TABLE 92 REST OF EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
FIGURES LIST
FIGURE 1 EUROPE TOPICAL DRUG DELIVERYMARKET: SEGMENTATION
FIGURE 2 EUROPE TOPICAL DRUG DELIVERY MARKET: GEOGRAHIC SCOPE
FIGURE 3 EUROPE TOPICAL DRUG DELIVERYMARKET: DATA TRIANGULATION
FIGURE 4 EUROPE TOPICAL DRUG DELIVERY MARKET: SNAPSHOT
FIGURE 5 EUROPE TOPICAL DRUG DELIVERYMARKET: BOTTOM UP APPROACH
FIGURE 6 EUROPE TOPICAL DRUG DELIVERYMARKET: TOP DOWN APPROACH
FIGURE 7 EUROPE TOPICAL DRUG DELIVERYMARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 EUROPE TOPICAL DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
FIGURE 9 EUROPE TOPICAL DRUG DELIVERY MARKET: BY INDICATION, SNAPSHOT 2016
FIGURE 10 EUROPE TOPICAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 11 EUROPE TOPICAL DRUG DELIVERYMARKET: BY END-USER, SNAPSHOT 2016
FIGURE 12 EUROPE TOPICAL DRUG DELIVERY MARKET:BY GEOGRAPHY, 2016
FIGURE 13 EUROPE TOPICAL DRUG DELIVERY PRESCRIPTION DRUGS MARKET: COMPANY SHARE 2016 (%)
COMPNIES PROFILES
MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc.
FIGURE 1 EUROPE TOPICAL DRUG DELIVERYMARKET: SEGMENTATION
FIGURE 2 EUROPE TOPICAL DRUG DELIVERY MARKET: GEOGRAHIC SCOPE
FIGURE 3 EUROPE TOPICAL DRUG DELIVERYMARKET: DATA TRIANGULATION
FIGURE 4 EUROPE TOPICAL DRUG DELIVERY MARKET: SNAPSHOT
FIGURE 5 EUROPE TOPICAL DRUG DELIVERYMARKET: BOTTOM UP APPROACH
FIGURE 6 EUROPE TOPICAL DRUG DELIVERYMARKET: TOP DOWN APPROACH
FIGURE 7 EUROPE TOPICAL DRUG DELIVERYMARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 EUROPE TOPICAL DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
FIGURE 9 EUROPE TOPICAL DRUG DELIVERY MARKET: BY INDICATION, SNAPSHOT 2016
FIGURE 10 EUROPE TOPICAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 11 EUROPE TOPICAL DRUG DELIVERYMARKET: BY END-USER, SNAPSHOT 2016
FIGURE 12 EUROPE TOPICAL DRUG DELIVERY MARKET:BY GEOGRAPHY, 2016
FIGURE 13 EUROPE TOPICAL DRUG DELIVERY PRESCRIPTION DRUGS MARKET: COMPANY SHARE 2016 (%)
COMPNIES PROFILES
MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc.
